Rebecca Jackson, MDRebecca D. Jackson, MD
Director, The Center for Clinical and Translational Science
PI, NCATS Clinical and Translational Science Award

376 West 10th Avenue, Suite 260
Columbus, OH 43210

Phone: 614-293-4041
Email Dr. Jackson

Rebecca Jackson, MD

Rebecca D. Jackson, MD, is the Max Morehouse Chair of Cancer Research, founding Director of the Ohio State University Center for Clinical and Translational Science, Associate Dean for Clinical and Translational Research, and Professor of Endocrinology, Diabetes and Metabolism at The Ohio State University.


Her research is concentrated in the area of women’s health with a specific focus on defining clinical factors, biomarkers and genetic associations for diseases that disproportionately affect women including osteoporotic fractures, osteoarthritis and cardiovascular disease as well as characterizing the effects of environmental factors such as physical activity, dietary factors and medication exposure (e.g. postmenopausal estrogen or calcium plus D) that modify disease risk. More recently, she brought together a research team across 6 Ohio academic centers, 19 community partners, and RecoveryOhio to participate in the NIDA-funded HEALing Communities Study, a parallel-arm, cluster-randomized, wait-list controlled trial of a community-engaged intervention using a phased, data-driven planning process to mobilize communities to identify and implement evidence-based opioid interventions to reduce opioid overdose deaths by 40%.


Dr. Jackson’s laboratory has had continuous NIH support for more than 3 decades and she has authored or co-authored more than 270 peer-reviewed manuscripts including the landmark Women’s Health Initiative Calcium plus vitamin D trial, the estrogen plus progestin trial, and conducted the first genome-wide association study to elucidate genetic variants associated with risk for hip fractures.


Dr. Jackson is also a nationally recognized leader in supporting the education and training of translational scientists and has served as the Lead of the Workforce Development Domain Task Force for the CTSA Consortium, PI for an Administrative supplement to develop a semantically-anchored federated platform for educational resource sharing (the N-Lighten Network), mPI for a NCI U24 grant to coordinate workshops for the career development of early-career cancer investigators and she has been an invited panelist on a number of workforce taskforces through FASEB, ACT, and NIH. She has served as a member of the Board of Directors of the Clinical Research Forum, past Chair of the Steering Committee of the Women’s Health Initiative and the CTSA consortium, past president for the Association of Clinical and Translational Science, and past member of the NIH Advisory Board for Clinical Research. She has been the recipient of numerous awards including the Kellogg National Fellowship, the Ohio Women’s Hall of Fame, the AACR Team Science Award, the ACTS Team Science Award and the Barry Coller Distinguished Service Award from ACTS. In 2008, she was elected as a Fellow of the American Association for the Advancement of Science and in 2015, she received the OSU Distinguished Scholar Award, one of the University’s highest research honors.


Pediatric Director:

Bill Smoyer, MDWilliam E. Smoyer, MD
Vice President for Clinical and Translational Research at NCH
Director of the Center for Clinical and Translational Research at NCH

The Research Institute at Nationwide Children's Hospital
700 Children's Drive
Columbus, OH 43205

Phone: 614-722-2683
Email Dr. Smoyer

For the past 20 years, William E. Smoyer, MD, has focused his career on basic, clinical, and translational research to improve our understanding of the molecular regulation of podocyte injury during nephrotic syndrome, and to develop more targeted and effective novel treatments for childhood nephrotic syndrome.

His work has led to publications in the Journal of Clinical Investigation, FASEB, the Journal of the American Society of Nephrology, as well as several subspecialty journals.

Smoyer oversees the majority of clinical and translational research initiatives by pediatric researchers, and seeks opportunities to integrate pediatrics into all CCTS activities, including education, informatics, translational technologies, research design and implementation programs, and resource allocation. Under his leadership, NCH has expanded its strategic prioritization of clinical and translational research over the last decade, including an extensive array of core services to fully support clinical research on the NCH and OSU campuses.